|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
USP-1268819 |
USP |
Etoposide Phosphate 200 mg |
|
654.67 CHF
711.63 €
|
|
|
|
USP-1268839 |
USP |
Etonogestrel Related Compound B (13-Ethyl-6Beta,17Beta-dihydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one) 10 mg |
|
1,332.00 CHF
1,447.88 €
|
|
|
|
USP-1268841 |
USP |
Etonogestrel Related Compound C (13-Ethyl-17Beta-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-4-en-20-yn-3,6-dione) 10 mg |
|
1,332.00 CHF
1,447.88 €
|
|
|
|
USP-1268852 |
USP |
Etoposide Resolution Mixture - BACKORDER 10 mg |
|
1,630.67 CHF
1,772.54 €
|
|
|
|
USP-1268892 |
USP |
Etodolac Peak Identification Mixture 15 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1268900 |
USP |
Eucalyptol 200 mg |
|
456.00 CHF
495.67 €
|
|
|
|
USP-1268919 |
USP |
Eucalyptus Oil 1 g |
|
557.33 CHF
605.82 €
|
|
|
|
USP-1268943 |
USP |
Etonogestrel Related Compound D (17Beta-Hydroxy-11-methylene-19-nor-17alpha-pregn-4-en-20-yn-3-one) 10 mg |
|
1,332.00 CHF
1,447.88 €
|
|
|
|
USP-1268954 |
USP |
Etonogestrel Related Compound E (13-Ethyl-17Beta-hydroxy-11-methylene-18,19-dinor-17alpha-pregn-5-en-20-yn-3-one) 10 mg |
|
1,332.00 CHF
1,447.88 €
|
|
|
|
USP-1268965 |
USP |
Eugenol 500 mg |
|
436.00 CHF
473.93 €
|
|
|
|
USP-1268976 |
USP |
Everolimus 300 mg |
|
3,348.00 CHF
3,639.28 €
|
|
|
|
USP-1268987 |
USP |
Everolimus System Suitability Mixture (This is a mixture of everolimus, everolimus oxepane isomer and 9-O-hydroxyethyl sirolimus) 25 mg |
|
3,482.67 CHF
3,785.66 €
|
|
|
|
USP-1268998 |
USP |
[Glu13]-Exenatide - Biologic 1 mg |
|
1,868.00 CHF
2,030.52 €
|
|
|
|
USP-1269009 |
USP |
[Met(O)14]-Exenatide - Biologic 1 mg |
|
1,868.00 CHF
2,030.52 €
|
|
|
|
USP-1269017 |
USP |
Evening Primrose Oil 1 g |
|
453.33 CHF
492.77 €
|
|
|
|
USP-1269028 |
USP |
Ezetimibe 250 mg |
|
801.33 CHF
871.05 €
|
|
|
|
USP-1269039 |
USP |
Ezetimibe System Suitability Mixture (A mixture containing Ezetimibe and o-Fluorobenzene isomer and R,R,S-Ezetimibe) 20 mg |
|
1,710.67 CHF
1,859.50 €
|
|
|
|
USP-1269045 |
USP |
[N-Acetyl-His1]-Exenatide - Biologic 1 mg |
|
1,649.33 CHF
1,792.82 €
|
|
|
|
USP-1269050 |
USP |
Exemestane 150 mg |
|
492.00 CHF
534.80 €
|
|
|
|
USP-1269061 |
USP |
Exemestane Related Compound A - 6-Methyleneandrosta-4-ene-3,17-dione 15 mg |
|
1,356.00 CHF
1,473.97 €
|
|
|
|
USP-1269072 |
USP |
Exemestane Related Compound B - 6-hydroxymethylandrostra-1,4-diene-3,17-dione 15 mg |
|
1,529.33 CHF
1,662.38 €
|
|
|
|
USP-1269094 |
USP |
Exemestane System Suitability Mixture 25 mg |
|
1,650.67 CHF
1,794.28 €
|
|
|
|
USP-1269105 |
USP |
Exenatide - Biologic 2,73 mg |
|
1,880.00 CHF
2,043.56 €
|
|
|
|
USP-1269119 |
USP |
FAME Standard Mixture - A mixture of 25 Fatty Acid Methyl Esters 100 mg |
|
504.00 CHF
547.85 €
|
|
|
|
USP-1269130 |
USP |
Famciclovir Related Compound E - 2-aminopurine 25 mg |
|
1,216.00 CHF
1,321.79 €
|
|
|
|
USP-1269141 |
USP |
Famciclovir Related Compound F - 2-Amino-6-chloropurine 25 mg |
|
1,276.00 CHF
1,387.01 €
|
|
|
|
USP-1269152 |
USP |
Famciclovir 200 mg |
|
474.67 CHF
515.97 €
|
|
|
|
USP-1269163 |
USP |
Famciclovir System Suitability Mixture Mixture of Famciclovir, Propionylfamciclovir and 6-Chlorofamciclovir 20 mg |
|
1,650.67 CHF
1,794.28 €
|
|
|
|
USP-1269174 |
USP |
Famciclovir Related Compound A - 2-[2-(2-Amino-9H-purin-9-yl)ethyl]propane-1,3-diol hydrochloride 20 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1269185 |
USP |
Famciclovir Related Compound B - 4-(2-Amino-9H-purin-9-yl)-2-(hydroxymethyl)butyl acetate 20 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1269196 |
USP |
Famciclovir Related Compound C - 4-(2-amino-9H-purin-9-yl)-2-methylbutyl acetate 20 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1269200 |
USP |
Famotidine 125 mg |
|
406.67 CHF
442.05 €
|
|
|
|
USP-1269221 |
USP |
Famotidine Related Compound B (3,5-Bis[2-[[2-[(diaminomethylene)amino]thiazol-4-yl]methylthio]ethyl]-4H-1,2,4,6-thiatriazine 1,1-dioxide) 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1269232 |
USP |
Famotidine Related Compound C - 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]-N-sulfamoylpropanamide Hydrochloride (HCl) 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1269243 |
USP |
Famotidine Related Compound D - 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1269254 |
USP |
Famotidine Related Compound E - 2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1269265 |
USP |
Famotidine Related Compound F - 3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid 25 mg |
|
1,568.00 CHF
1,704.42 €
|
|
|
|
USP-1269312 |
USP |
Felbamate 250 mg |
|
1,592.00 CHF
1,730.50 €
|
|
|
|
USP-1269323 |
USP |
Felbamate Related Compound A - 3-Hydroxy-2-phenylpropyl carbamate 25 mg |
|
1,528.00 CHF
1,660.94 €
|
|
|
|
USP-1269334 |
USP |
Felbamate Related Compound B - Phenethyl carbamate 25 mg |
|
1,372.00 CHF
1,491.36 €
|
|
|
|
USP-1269356 |
USP |
Febantel 200 mg |
|
477.33 CHF
518.86 €
|
|
|
|
USP-1269367 |
USP |
Febantel Related Compound A - (Methyl [[2-[(methoxyacetyl)amino]-4-(phenylthio)phenyl]carbamimidoyl]carbamate) 15 mg |
|
833.33 CHF
905.83 €
|
|
|
|
USP-1269378 |
USP |
Febantel Related Compound B - (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole) 15 mg |
|
833.33 CHF
905.83 €
|
|
|
|
USP-1269389 |
USP |
Felodipine 300 mg |
|
456.00 CHF
495.67 €
|
|
|
|
USP-1269390 |
USP |
Felodipine Related Compound A (3-Ethyl 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethylpyridine-3,5-dicarboxylate) 15 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1269403 |
USP |
Fenbendazole 100 mg |
|
1,414.67 CHF
1,537.75 €
|
|
|
|
USP-1269414 |
USP |
Fenbendazole Related Compound A - Methyl(1H-benzimidazole-2-yl)carbamate 30 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1269425 |
USP |
Fenbendazole Related Compound B - Methyl[5(6)-chlorobenzimidazole-2-yl]carbamate 30 mg |
|
1,454.67 CHF
1,581.23 €
|
|
|
|
USP-1269436 |
USP |
Fenofibric Acid - (2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic acid) 250 mg |
|
716.00 CHF
778.29 €
|
|
|
|
USP-1269447 |
USP |
Fenofibrate 200 mg |
|
492.00 CHF
534.80 €
|
|
